23 results
8-K
EX-99.2
HROW
Harrow Inc
13 May 24
Harrow Announces First Quarter 2024 Financial Results
4:25pm
to the Harrow team to oversee our branded business, John Saharek, ImprimisRx’s President and CEO, will be focused on the day-to-day management of our
8-K
EX-99.1
d32 wm7db1
2 Feb 15
Imprimis Pharmaceuticals Announces Two Key Leadership Promotions
12:00am
PRE 14A
bg85ad5u
5 Jul 13
Preliminary proxy
12:00am
424B4
p3iueh4 lctfrdzg
11 Feb 13
Prospectus supplement with pricing info
12:00am